Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Colorado · 2025 Regular Session · Bill

SB 25-066: State Contracts with Opioid Antagonist Businesses

Introduced Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 25-066 is a bill introduced in the Colorado Senate on January 22, 2025. According to its official title, it concerns: State Contracts with Opioid Antagonist Businesses. Primary sponsor: Kyle Mullica (Democratic), Paul Lundeen. Most recent recorded action (February 26, 2025): Senate Committee on Health & Human Services Postpone Indefinitely.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Under current law, the opioid antagonist bulk purchase fund (fund) allows the department of public health and environment (department) to bulk purchase opioid antagonists and distribute them to eligible entities. In contracting for the bulk purchasing and distribution of opioid antagonists, the bill requires the department to contract with an opioid antagonist medication distributor. However, the bill prohibits the department from contracting with an opioid antagonist medication distributor if the distributor: Was found liable for the manufacture or distribution of an opioid that resulted in an opioid-related overdose; Is or was a liable party to a settlement agreement for the manufacture or distribution of an opioid that resulted in an opioid-related overdose; or Is or was liable for a fine or penalty levied by a governmental entity for the manufacture or distribution of an opioid that resulted in an opioid-related overdose. The bill requires the department to implement a competitive selection process for the bulk purchase of opioid antagonists. The bill declares any contract or agreement that does not comply with the contracting requirements of the bill is void and unenforceable. (Note: This summary applies to this bill as introduced.)

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Kyle MullicaPrimary sponsorDemocraticSenate24
Paul LundeenPrimary sponsorNot applicable (committee)——

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Senate Committee on Health & Human Services Postpone Indefinitely
  2. Introduced In Senate - Assigned to Health & Human Services

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source